Fresenius reported €1.68B in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Akzo Nobel AKZA:NA € 361M 31M
Alcon AG ALC:SW 500M 155M
AstraZeneca AZN:LN 2149M 322M
BASF BAS:GR € 3055M 7M
Bayer BAYN:GR € 3035M 1119M
Davita Healthcare Partners DVA:US $ 653.14M 52.9M
DSM DSM:NA € 390M 7M
E.ON EOAN:GR 3.4B 739M
Fresenius FRE:GR € 1684M 48M
Fresenius Medical Care FME:GR € 798M 36M
Getinge GETIB:SS SK 1630M 168M
Givaudan GIVN:VX 816M 141M
GlaxoSmithKline GSK:LN 2626M 584M
GN Store Nord GN:DC DK 875M 111M
GRIFOLS GRF:SM € 330.18M 44.07M
Hikma Pharmaceutical HIK:LN 358M 9M
Lonza Group LONN:SW 847M 291M
Merck MRK:GR € 1576M 61M
Novartis NOVN:VX SF 4772M 423M
Philips PHIA:NA € 783M 202M
RWE RWE:GR € 1678M 913M